Therapeutic Asset Ratings

748 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Kras Peptide Vaccine High Risk Cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1	CC (43)
Lm-Gucy2C Vaccine Small Intestine Adenocarcinoma	Thomas Jefferson University	P1	CC (43)
Medium Dose Msh2-/- Tumor Cell Vaccine Colorectal Cancer	West China Hospital	P1	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Adult Solid Neoplasm	City of Hope Medical Center	P1	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Urinary Bladder Carcinoma	City of Hope Medical Center	P1	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Estrogen-Receptor Negative Breast Cancer	City of Hope Medical Center	P1	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Her2-Receptor Negative Breast Cancer	City of Hope Medical Center	P1	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Non-Small Cell Lung Carcinoma	City of Hope Medical Center	P1	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Progesterone-Receptor Negative Breast Cancer	City of Hope Medical Center	P1	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Triple-Negative Breast Carcinoma	City of Hope Medical Center	P1	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Neoplasm	City of Hope Medical Center	P1	CC (43)
muc1 peptide vaccine Ductal Breast Carcinoma In Situ	Finn, Olivera, PhD	P1	CC (43)
Multi-Epitope Her2 Peptide Vaccine H2Nvac Ductal Breast Carcinoma In Situ	Mayo Clinic	P1	CC (43)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Hematopoietic Cell Transplant Recipient	City of Hope Medical Center	P1	CC (43)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine High Grade B-Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Myelodysplastic/Myeloproliferative Neoplasm	City of Hope Medical Center	P1	CC (43)
Necvax-Neo1 Solid Tumors, Adult	NEC OncoImmunity AS	P1	CC (43)
Neoantigen Personalized Cancer Vaccine Digestive System Neoplasm	Ruijin Hospital	P1	CC (43)
Neoantigen Personalized Cancer Vaccine Neoplasm	Ruijin Hospital	P1	CC (43)
Neovax Lymphoid Leukemia	Dana-Farber Cancer Institute	P1	CC (43)
Oncolytic Measles Virus Encoding Helicobacter Pylori Neutrophil-Activating Protein Invasive Breast Carcinoma	Mayo Clinic	P1	CC (43)
Oncolytic Measles Virus Encoding Helicobacter Pylori Neutrophil-Activating Protein Breast Adenocarcinoma	Mayo Clinic	P1	CC (43)
Oncolytic Measles Virus Encoding Helicobacter Pylori Neutrophil-Activating Protein Breast Carcinoma	Mayo Clinic	P1	CC (43)
Optimized Neoantigen Synthetic Long Peptide Vaccine Infiltrating Bladder Urothelial Carcinoma	Washington University School of Medicine	P1	CC (43)
Panda-Vac Squamous Cell Lung Carcinoma	UNC Lineberger Comprehensive Cancer Center	P1	CC (43)

Showing 476 to 500 of 748 assets

PreviousPage 20 of 30Next